June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

Baystreet.ca News Commentary – As cancer rates continue to climb worldwide, the race to develop better, faster, and more ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory (LLNL), BBOT (BridgeBio Oncology Therapeutics ...

Cambridge: AstraZeneca has announced that Datroway (datopotamab deruxtecan or Dato-DXd) has received accelerated approval ...

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc.

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...